Fill out the form to download brochures
System layout brochure
EarlySense All-in-One brochure
EarlySense Safety brochure
EarlySense Vitals brochure
Selected case studies booklet
I would like more information on
First Name*:
Last Name*:
Mailing address:
Mailing address (line 2):
May 8, 2018
American Addiction Centers 1st to Implement AI Technology to Improve Patient Safety During Detox


AAC to adopt EarlySense™ technology as a standard of care for detox treatment;
utilizing Artificial Intelligence (AI) to identify irregular vital signs early


BRENTWOOD, Tenn., May 8, 2018 — American Addiction Centers (AAC) is taking patient safety to a new level in the addiction industry as the first treatment provider to utilize EarlySense™ technology during detox. This potentially life-saving technology provides medical staff with real-time data to identify irregular vital signs which is crucial for patient safety in the detox phase of treatment. Over the next few months, American Addiction Centers, which owns and operates more than 30 treatment facilities in the U.S., will implement this cutting-edge technology as a standard of care at all of its facilities with detox services.


To learn about AAC’s treatment centers and the services they provide, visit:


“As a leader in the industry, it was important for us to not only find a solution that would help us meet our long-term patient safety initiatives as a company, but also pave the way for addiction treatment providers at large,” said American Addiction Centers’ CEO, Michael Cartwright. “Detox is such a critical point in a patient’s recovery journey, but it is often met with unforeseen clinical challenges. With EarlySense, our medical staff is alert and ready to intervene at all times giving our patients and their loved ones peace-of-mind.”


The FDA-cleared patient monitoring system uses a sensor placed beneath the mattress to continuously tracks the patient’s heart rate, breathing patterns and movements without attaching any wires to the patient. Concerning changes, such as irregular heart beats or breathing patterns and sudden movements, will immediately distribute real-time alerts to a central nursing hub, tablets, and mobile devices, providing nurses with ample time to proactively respond.


“Withdrawal is one of the most dangerous steps in the recovery process and can be deadly in some cases due to the severity of its symptoms,” said Dr. Mark Calarco, national medical director of American Addiction Centers. “That said, it’s imperative that patients in detox are under close supervision. EarlySense monitoring enables our clinicians to consistently monitor those in detox and identify early signs of patient deterioration, likely to happen during withdrawal, especially late at night, controlling these high-risk situations before they escalate.”


Nursing staff are also able to customize each patient’s monitor and alerts allowing for completely personalized care and better response times, while also minimizing false alarms.


“This partnership represents an expansion of the clinical utilization of the EarlySense system to assist clinicians in providing the highest level of care as patients begin the process of addiction recovery”, said Tim O’Malley, president of EarlySense Inc. “In the United States we continue to see the toll that addiction has on patients and their families, and the staggering number of lives impacted each day. Partnering with American Addiction Centers, with their holistic approach to recovery, is a great fit with EarlySense and our desire to provide proactive, continuous monitoring in an effort to prevent adverse events. We continue to see the value of advanced monitoring solutions outside of the hospital environment. This is a great example where a new frontier of addiction centers under the leadership of American Addiction Centers becomes an area for advanced monitoring and analytics.”

The technology was first introduced at AAC’s Southern California facility, Laguna Treatment Hospital which frequently treats patients in need of higher levels of care.


“On multiple occasions, EarlySense has detected abnormal vital signs while the patient was resting in bed identifying various diagnosis such as pneumonia, respiratory distress, and countless others,” said Mertis Shearry, director of nursing at Laguna Treatment Hospital. “Patients and loved ones can be certain that with the help of this technology, nursing staff are ready to provide early medical interventions if needed.”


EarlySense is also available at two other AAC facilities – River Oaks Treatment Center and Recovery First.


“Ultimately, our goal is to revolutionize the treatment of addiction and transform lives in the process,” said Cartwright. “By investing in the EarlySense technology company-wide, we are one step closer toward reaching that goal.”


About American Addiction Centers

American Addiction Centers (NYSE: AAC) is a leading provider of inpatient and outpatient substance abuse treatment services. We treat clients who are struggling with drug addiction, alcohol addiction, and co-occurring mental/behavioral health issues. We currently operate substance abuse treatment facilities located throughout the United States. These facilities are focused on delivering effective clinical care and treatment solutions. For more information, please find us at or follow us on Twitter @AAC_Tweet.


About EarlySense

EarlySense® provides contact-free, continuous monitoring solutions for the medical and consumer digital health markets. EarlySense’s FDA-cleared systems utilize Artificial Intelligence (AI) and big data analytics to provide actionable health insights and improve clinical outcomes.


Used worldwide in hospitals, rehab and skilled nursing facilities, EarlySense assists clinicians in early detection of patient deterioration, helping to prevent adverse events, including code blues which are a result of cardiac or respiratory arrest, preventable ICU transfers, patient falls and pressure ulcers. EarlySense offers clinically-proven technology to consumers with EarlySense® Live™ and Percept™. EarlySense® Live™ is the first at-home consumer health monitor powered by EarlySense’s medically-proven sensor and AI analytics.


EarlySense has partnered with leading global technology companies including Samsung, Welch Allyn, iFit and Beurer. The company is based in Ramat Gan, Israel and Woburn, Massuchusetts. For more information, visit



american addiction center logo

Media Contacts

Joy Sutton, PR Manager

American Addiction Centers




Courtney Obecny, Product Marketing Manager

EarlySense Inc